IP Library Granted Patent US 8,689,971
Granted Patent B2
US 8,689,971 · App. 12/229,771 · Granted Apr 8, 2014

Contact lens packaging solutions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,689,971
App. No.
12/229,771
Granted
Apr 8, 2014
Kind
B2
Abstract

The present invention relates to improved contact lens products which not only have initial insertion comfort. The contact lens product of the invention comprises a soft hydrogel contact lens immersed and autoclaved in a packaging solution including a low molecular weight polyethylene glycol (PEG) (or glycerin) and a homopolymer or copolymer of vinylpyrrolidone. The present invention also provides methods for making contact lens products of the invention.

Claims (24)

1. An ophthalmic product, comprising a sealed and sterilized package which include a packaging solution and a soft hydrogel contact lens immersed in the packaging solution,

wherein the packaging solution includes:

a copolymer of vinylpyrrolidone and at least one amino-containing vinylic monomer, wherein the amino-containing vinylic monomer is selected from the group consisting of alkylaminoalkylmethacrylate having 8-15 carbon atoms, alkylaminoalkylacrylate having 7-15 carbon atoms, dialkylaminoalkylmethacrylate having 8-20 carbon atoms, dialkylaminoalkylacrylate having 7-20 carbon atoms, and N-vinylalkylamide having 3-10 carbon atoms, wherein the copolymer of vinylpyrrolidone is present in an amount sufficient to provide the packaging solution a viscosity of up to about 5.0 centipoises at 25° C., wherein the copolymer of vinylpyrrolidone has a molecular weight sufficiently large to form a cushion layer on the soft hydrogel contact lens;

a polyethylene glycol having an average molecular weight of about 600 or less;

an α-oxo-multi-acid or salt thereof in an amount sufficient to have a reduced susceptibility to oxidation degradation of the polyethylene glycol in the packaging solution; and

one or more buffering agents in an amount sufficient to provide the solution a pH of from about 6.0 to 8.0,

wherein the packaging solution has an osmolality of from about 200 to about 450 mOsm/kg.

2. The ophthalmic product of claim 1 , wherein the hydrogel contact lens is a silicone hydrogel contact lens.

3. The ophthalmic product of claim 1 , wherein the amino-containing vinylic monomer is dimethylaminoethylmethacrylate or dimethylaminoethylacrylate.

4. The ophthalmic product of claim 1 , wherein the packaging solution has a viscosity of up to about 3.0 centipoises at 25° C.

5. The ophthalmic product of claim 1 , wherein the packaging solution comprises a polyethylene glycol having an average molecular weight of about 600 or less.

6. The ophthalmic product of claim 1 , wherein the α-oxo-multi-acid is selected from the group consisting of citric acid, 2-ketoglutaric acid, and malic acid.

7. The ophthalmic product of claim 1 , wherein the α-oxo-multi-acid is citric acid.

8. The ophthalmic product of claim 1 , wherein hydrogel contact lens includes one or more leachable lubricant therein.

9. The ophthalmic product of claim 2 , wherein the packaging solution comprises glycerin.

10. The ophthalmic product of claim 2 , wherein the packaging solution comprises a polyethylene glycol having an average molecular weight of about 600 or less.

11. The ophthalmic product of claim 9 , wherein the amino-containing vinylic monomer is dimethylaminoethylmethacrylate or dimethylaminoethylacrylate.

12. The ophthalmic product of claim 10 , wherein the amino-containing vinylic monomer is dimethylaminoethylmethacrylate or dimethylaminoethylacrylate.

13. The ophthalmic product of claim 11 , wherein the packaging solution has a viscosity of up to about 3.0 centipoises at 25° C.

14. The ophthalmic product of claim 12 , wherein the packaging solution has a viscosity of up to about 3.0 centipoises at 25° C.

15. The ophthalmic product of claim 13 , wherein the α-oxo-multi-acid is selected from the group consisting of citric acid, 2-ketoglutaric acid, and malic acid.

16. The ophthalmic product of claim 14 , wherein the α-oxo-multi-acid is selected from the group consisting of citric acid, 2-ketoglutaric acid, and malic acid.

17. The ophthalmic product of claim 13 , wherein the α-oxo-multi-acid is citric acid.

18. The ophthalmic product of claim 14 , wherein the α-oxo-multi-acid is citric acid.

Assignments (2)
CONFIRMATORY DEED OF ASSIGNMENT EFFECTIVE APRIL 8, 2019 Recorded Dec 10, 2019
From: NOVARTIS AG
To: ALCON INC.
Reel/Frame 051454/0788 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2009
From: MINICK, KASEY JON; CARNEY, FIONA PATRICIA; SENTELL, KAREN BELINDA; MINNO, GEORGE EDWARD
To: NOVARTIS AG
Reel/Frame 022239/0710 →